Emerging Opportunities in Wet Macular Degeneration Market
Macular degeneration is a weakening or collapsed working of the eyes’ macula. Macula is the small area on the retinal surface covered by the light-sensitive tissue lining which is blackish area of the eye. This part of the retina is responsible for individual’s central vision, allows viewing fine objects clearly. Generally old aged people develop macular degeneration because of natural aging process of the body. There are two types of macular degeneration namely dry (atrophic or non-neovascular) and wet (exudative or neovascular). Wet macular degeneration is a beginning of abnormal growth of blood vessels underneath the retina, these overgrown blood vessels leak blood which hamper clarity of central vision leading to macular degeneration. The prevalence of people living with wet macular degeneration is less as compared to dry form, but it causes more damage to central or detail vision.
Obtain Report Details: http://www.transparencymarketresearch.com/wet-macular-degeneration-market.html
Wet Macular Degeneration Market: Drivers and Restraints
Macular degeneration occurs in people above 60 years of age whereas younger people are also at risk. According to study conducted by AMD (Age related Macular Degeneration) Alliance International, approximately 30 million people live with AMD worldwide out of which 10-15% have wet type of macular degeneration. The increasing number of old age population all over the world is creating the high rise demand in wet macular degeneration market. According to World Health Organization (WHO) report, percentage of old people (above age of 60 years) has increased from 9.2% in 1990 to 11.7% in 2013 and expected to become 21.1% by year 2050. The total number of old age people all over the world was 841 million in 2013 and number is probable to touch 2 billion in 2050. All these facts represent high demand for the products for the treatment of wet macular degeneration globally in coming future. The technological advancements in diagnosis of macular degeneration and suitable reimbursement circumstances are driving the growth of the market. On the other hand high cost involved and limited awareness in developing world may hinder the growth of the global wet macular degeneration market. In last couple of years, many companies have invested heavily in research and development of drugs on wet macular degeneration such as Allergan completed Stage 3, Phase 2 study of abicipar pegol. In a 2010, VisionCare Ophthalmic Technologies, developed and got approval from FDA for implantable device that magnifies images on the retina to improve central vision compromised by macular degeneration.
Wet Macular Degeneration Market: Segmentation
Wet macular degeneration market can be segmented according to different categories such as geography, types of products. Geographically, this market can be segmented in four regions namely North American, Europe, Asia-Pacific and Rest of the World, out of all these segments North America region have highest contribution in terms of value because of more awareness and higher percentage of total income spent on healthcare compared to other economies. Followed by this, Europe, Asia-Pacific and Rest of the World respectively are major segments of the market. However the growth of the market may be significant in emerging economies in Asia and Africa looking at increasing number of old age population. The market can also be segmented according to products such as devices and drugs. In current scenario, clinicians are relied on drugs rather than devices (implantable telescopes) as it cost very high and yet to get popularity among medical fraternity.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15734
Wet Macular Degeneration Market: Company Profiles
Currently various established companies in pharmaceuticals, especially in ophthalmology market which are catering varied range of products for wet macular degeneration, out of which companies such as Alcon Nordic, Genzyme Corporation, Boehringer Ingelheim GmbH, EyeGate Pharmaceuticals, Inc., EyeCyte, Inc., PanOptica, Inc. and Ophthotech Corp. are leading contributors this market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Opportunities in Wet Macular Degeneration Market here
News-ID: 512489 • Views: 462
More Releases from TMR - Research Reports
Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to
More Releases for Macula
Macular Edema Treatment Market Evolving Industry Trends and key Insights by 2026 …
Macular edema is the condition characterized by abnormal leakage and accumulation of fluid that forms blister in the layer of macula. The macula is an oval-shaped pigmented area near the center of retina. This blister causes the macula to swell and thicken that causes distortion of vision. Although macular edema has numerous causes, the most common cause is diabetes. Other causes include, age-related macular degeneration, replacement of lenses in treatment
Macular Edema Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, …
Macular edema causes the building-up of fluid in macula region of the eye. The macula is a light sensitive tissue, present at the center of the retina and is responsible for the sharp, straight headed vision. Building-up of fluid in macula region leads the vision to distort. Diabetic retinopathy (which is most common in diabetic patients) is observed as the common cause of macular edema. Access Report Overview: https://www.psmarketresearch.com/market-analysis/macular-edema-therapeutics-pipeline-analysis
Macular Edema Therapeutics Market Estimated to Flourish by 2017 – 2025
Some of the major key player for macular edema therapeutics market globally are Allergan, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals, Inc., Pfizer, Inc., Bayer AG, Bausch & Lomb Incorporated. Another prominent player in the macular edema markets are Aciont Inc., ActiveSite, Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., Aerpio Therapeutics, Inc., Ampio Pharmaceuticals, Inc., Araim Pharmaceuticals, Inc., Astellas Pharma Inc.,Boehringer , Ingelheim GmbH. The change in life style have the
In-depth Analysis of Global Age-related Macular Degeneration Market to grow at a …
ResearchMoz added Latest Research Report titled " Global Age-related Macular Degeneration Market 2016-2020 " to it's Large Report database. About AMD AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops
Growth Macular Edema Therapeutics Market: 2017 - 2025
Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cystoids macular edema (CME) and diabetic macular edema (DME). The retina is the light-sensitive tissue at the back of the eye
Global Age-Related Macular Degeneration Market to grow at a CAGR of 7.37% during …
About AMD AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While